MedPlus Health Services Limited

Equities

MEDPLUS

INE804L01022

Drug Retailers

Market Closed - NSE India S.E. 07:43:49 2024-05-02 am EDT 5-day change 1st Jan Change
681.8 INR -2.17% Intraday chart for MedPlus Health Services Limited -1.02% -9.18%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Medplus Health Services Arm Gets Order for Temporary Suspension of Operations MT
Optival Health Solutions Private Limited Received Order for Temporarily Suspending the Operations of A Store Situated At Bhagya Nagar, Karimnagar, Telangana CI
Nomura Adjusts Medplus Health Services' Price Target to INR982 From INR974, Keeps at Buy MT
Transcript : MedPlus Health Services Limited, Q3 2024 Earnings Call, Feb 05, 2024
India's MedPlus posts muted Q3 profit growth as expenses weigh RE
MedPlus Health Services Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Medplus Health Services Limited Announces Resignation of Surendranath Mantena, Chief Operating Officer CI
Telangana's Drug Control Authority Suspends Medplus Health Unit's License MT
India's Nifty set to open higher tracking Asian peers RE
Nomura Adjusts Medplus Health Services' Price Target to INR974 From INR952, Keeps at Buy MT
Transcript : MedPlus Health Services Limited, Q2 2024 Earnings Call, Nov 08, 2023
MedPlus Health Services Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Medplus Health Services Gets Board Nod to Raise Funds Via Equity or Debt. MT
MedPlus Health Services Limited Announces Resignation of Atul Gupta as Non-Executive Non-Independent Director CI
Transcript : MedPlus Health Services Limited, Q1 2024 Earnings Call, Aug 08, 2023
India's MedPlus Health reports 18% rise in Q1 profit on retail demand RE
MedPlus Health Services Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
23,861,140 Equity Shares of MedPlus Health Services Limited are subject to a Lock-Up Agreement Ending on 20-JUN-2023. CI
Nomura Adjusts Medplus Health Services' Price Target to INR952 From INR885, Keeps at Buy MT
Transcript : MedPlus Health Services Limited, Q4 2023 Earnings Call, May 26, 2023
India's MedPlus Health posts two-fold surge in Q4 profit on strong sales RE
MedPlus Health Services Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
MedPlus Health Services Limited Announces Executive Changes CI
Nomura Adjusts Medplus Health Services' Price Target to INR885 From INR928, Keeps at Buy MT
Transcript : MedPlus Health Services Limited, Q3 2023 Earnings Call, Feb 06, 2023
Chart MedPlus Health Services Limited
More charts
MedPlus Health Services Limited is an India-based omni channel retail pharmacy. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. It operates through two segments: Retail and Diagnostics. The Retail segment is engaged in retail trading of medicines and general items. The Diagnostics segment is engaged in the diagnostic services. The Company operates approximately 3,882 stores in 552 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its subsidiaries include Optival Health Solutions Private Limited, MHS Pharmaceuticals Private Limited, Kalyani Meditimes Private Limited, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
681.8 INR
Average target price
878.4 INR
Spread / Average Target
+28.84%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MEDPLUS Stock
  4. News MedPlus Health Services Limited
  5. Telangana's Drug Control Authority Suspends Medplus Health Unit's License